Reset filters
  • 7 March 2012

Once-a-month HIV drug maintains good levels for prevention; few side-effects so far

Read the article
  • 15 November 2011

Ritonavir dose of 50 mg could be sufficient to boost some protease inhibitors, trials needed

Read the article
  • 18 October 2011

US panel updates antiretroviral treatment guidelines

Read the article
  • 18 October 2011

Switching from efavirenz to rilpivirine single tablet is safe and effective

Read the article
  • 14 October 2011

Gene variant that helps hepatitis C treatment may hinder HIV treatment

Read the article
  • 14 October 2011

Raltegravir continues to perform well at four years

Read the article
  • 14 October 2011

Dolutegravir is potent but twice-daily works better for integrase-resistant

Read the article
  • 20 September 2011

Gene therapy for HIV is “progress towards functional cure” say researchers

Read the article
  • 7 September 2011

Once-daily etravirine does well in patients starting HIV therapy

Read the article

Receive the latest HIV research and conference news

Complete this form to receive regular email bulletins including the latest HIV research and conference news from aidsmap and/or updates from Terrence Higgins Trust.

Get regular email bulletins

Please let us know how you'd like to be contacted by ticking the options below.